[Efficacy and safety analysis of BTK inhibitors combined with R-CHOP regimen in newly diagnosed double-expressor diffuse large B-cell lymphoma] [0.03%]
新型布鲁顿酪氨酸激酶抑制剂联合R-CHOP方案治疗双表达型弥漫大B细胞淋巴瘤疗效及安全性分析
J B Lu,L Cao,H L Liu et al.
J B Lu et al.
Objective: To evaluate the efficacy and safety of Bruton tyrosine kinase inhibitor (BTKi) combined with R-CHOP regimen in newly diagnosed double-expressor diffuse large B-cell lymphoma (DE-DLBCL) . Methods: A retrospective analysis was cond...
[A preliminary study on the role of platelet mitochondria in the proliferation and metabolism of multiple myeloma cells] [0.03%]
[血小板线粒体在多发性骨髓瘤细胞增殖及代谢中作用的初步研究]
L Y Zhang,Y H Xiang,Y Y Li et al.
L Y Zhang et al.
Objective: To analyze platelet (PLT) characteristics and mitochondrial features in patients with multiple myeloma (MM) , and to investigate the impact of PLT mitochondrial respiration on MM cell proliferation, metabolism, and mitochondrial ...
[Clinical characteristics, treatment, and prognosis of double-hit multiple myeloma with concurrent 1q21+ and t (4;14)] [0.03%]
伴有1q21+和t(4;14)双重打击多发性骨髓瘤的临床特征、治疗及预后分析
Y Guo,N Qiao,Y Tao et al.
Y Guo et al.
Objective: To analyze the clinical characteristics, therapeutic regimens, and prognosis of double-hit multiple myeloma (DHMM) patients with concurrent 1q21 copy number gain (1q21+) and t (4;14) , and to explore effective strategies to impro...
Z J Xiao
Z J Xiao
Chronic myelomonocytic leukemia (CMML) is one of myeloid neoplasms originating from hematopoietic stem/progenitor cells, featuring both myelodysplastic and myeloproliferative characteristics. Significant revisions have been made to the diag...
[Chinese guidelines for diagnosis and treatment of myelodysplastic neoplasms (2026)] [0.03%]
中国骨髓增生异常肿瘤诊断与治疗指南（2023）
Chinese Society of Hematology, Chinese Medical Association
Chinese Society of Hematology
Myelodysplastic neoplasms (MDS) are a group of highly heterogeneous myeloid tumors originating from hematopoietic stem cells, clinically characterized by single or multiple lineage cytopenia with a risk of acute myeloid leukemia transformat...
[Research advances in clonal hematopoiesis associated with hematopoietic stem cell transplantation] [0.03%]
克隆性造血与造血干细胞移植研究进展
Z Jin,Y Y Chen,M Shan et al.
Z Jin et al.
With the development of high-throughput sequencing technology, clonal hematopoiesis has received extensive attention in the research of cardiovascular, cerebrovascular, and hematological diseases. Hematopoietic stem cell transplantation (HS...
[Advances in the prevention and treatment of acute graft-versus-host disease with cellular and novel targeted immunotherapy] [0.03%]
[细胞及新型靶向免疫治疗急性移植物抗宿主病预防和治疗的新进展]
S N Gao,Z L Xu,X J Huang
S N Gao
Acute graft-versus-host disease (aGVHD) remains a severe complication following allogeneic hematopoietic stem cell transplantation, and traditional corticosteroid therapy often demonstrates limited efficacy. This review highlights the recen...
[Aggressive systemic mastocytosis complicated with acute myeloid leukemia harboring the RUNX1::RUNX1T1 fusion gene: a case report] [0.03%]
系统性mastocytosis伴发携带RUNX1::RUNX1T1融合基因的急性髓系白血病一例报告
Y B Liu,X L Chen,L Zhang et al.
Y B Liu et al.
[Multiple myeloma with coexistence of IGH::FGFR3 and IGH::CCND1: two cases report and literature review] [0.03%]
IGH::FGFR3和IGH::CCND1共存的多发性骨髓瘤两例及文献复习
Y N Chang,Y R Wang,Q Sun et al.
Y N Chang et al.
We retrospectively analyzed the clinical data and clonal architecture of two multiple myeloma (MM) patients harboring concurrent IGH::FGFR3 and IGH::CCND1 fusions, with a review of relevant literature. Fluorescence in situ hybridization (FI...